FULH.B. Fuller Company
Is the business good?
A genuinely good business: 7 of 9 health tests passed and margins widening.
High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.
Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.
A balanced mix of margins, efficiency, and leverage. ROE 8% = margin × turnover × leverage.
Unless marked, from derived.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is FUL?
H.B. Fuller Company keeps 5.6% of every revenue dollar as profit after everything, against 4.8% for the median Specialty Chemicals name.
Net margin · Specialty Chemicals median 4.8% · 12 months to Q3 2026
- Share count, year on year
- −0.46%
Share count, year on year · flat: no meaningful dilution
- Gross margin
- 32%
Gross margin
| Year | Operating margin |
|---|---|
| FY2020 | 7.8% |
| FY2021 | 7.7% |
| FY2022 | 8.6% |
| FY2023 | 10% |
| FY2024 | 9.8% |
| FY2025 | 18% |
Details›
- Gross margin12 months to Q3 2026
- 32%
- Net margin12 months to Q3 2026
- 5.6%
- Free cash flow margin
- 2.8%
- Revenue, trailing twelve months
- $3.55B
- Free cash flow, trailing twelve months
- $100M
- Net income, trailing twelve months
- $198M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Specialty Chemicals
Ranks #14 of 33 by RyuScore